Connect with us

COVID-19

CDC: Two-Thirds of COVID-19 Patients Ages 12-17 are Obese

“Of the patients hospitalized for COVID-19, the most common underlying conditions were obesity”

Published

on

Obese

New t-shirts that read “Mandate Exercise” are gaining popularity and even the Center for Diseases Control and Prevention (CDC) may be all for it. Childhood obesity has already been deemed a pandemic for years, but the spread of coronavirus highlighted just how dangerous it is.

A recent study released by the Centers for Disease Control and Prevention found “approximately two-thirds of COVID-19 patients aged 12-17 were obese, and the length of stay in the hospital was twice that of non-obese adolescents” reports CBS17.

The CDC found that in addition to obesity, 34.7 percent of children with an underlying condition were more likely to be admitted to an intensive care unit than those without an underlying condition at 23.9 percent.

The study, which included hospitals in Arkansas, the District of Columbia, Florida, Illinois, Louisiana and Texas, found “of the patients hospitalized for COVID-19, the most common underlying conditions were obesity at 32.4 percent, followed by asthma at 10 percent, and then feeding tube dependence at 8.3 percent.

The researchers also found that the majority of the children hospitalized for COVID-19 were Black or Hispanic, and either under the age of 5 or between 12 and 17 years old. The study found that only 0.4 percent of those hospitalized adolescents who were vaccine-eligible were fully vaccinated.

In 2018 the CDC released a report that childhood obesity affected approximately 14 million children and adolescents in America. Add a viral pandemic to the equation and it does indeed look like “mandate exercise” is our best bet.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

COVID-19

Biden Admin Announces First COVID Shots For Kids Under 5 Likely By June 21

Published

on

Covid-19 vaccination record card with syringe and vial

On Thursday, the Biden administration announced that children under 5 will be able to get their first COVID-19 vaccination doses as soon as June 21, if regulators authorize the shots for this age group as expected.

According to the Associated Press, White House COVID-19 coordinator Ashish Jha “said the Food and Drug Administration’s outside panel of advisers will meet on June 14-15 to evaluate the Pfizer and Moderna shots for younger kids. Shipments to doctors’ offices and pediatric care facilities would begin soon after FDA authorization, with the first shots possible the following week.”

Jha added that states can begin placing orders for the pediatric vaccines on Friday and the administration will initially have 10 million doses available.

“Our expectation is that within weeks every parent who wants their child to get vaccinated will be able to get an appointment,” Jha said. “At the end of the day we all want to move fast, but we’ve got to get it right.”

The news comes the week after Pfizer announced that three doses of their vaccine offers strong protection against COVID-19 in children under 5.  However, according to former FDA Commissioner Dr. Scott Gottlieb, a third dose is unnecessary because the vaccines do not prevent infection.

“I think the decision matrix has changed around the vaccine for [ages] 6 months to 4 years old and so far as we know that the vaccine isn’t as protective at preventing infection,” Gottlieb said. “Previously, we had data showing that the childhood vaccine for 6 months to 4 years wasn’t as protective against infection as the adult vaccine.”

“That’s the reason why they pushed it out and asked for that third dose. But now, if the goal of the vaccine is to get baseline immunity in the kids to prevent really bad outcomes, and you’re really not using the vaccine as a tool to prevent infection in the first place, two doses could do that,” he added.

Continue Reading

COVID-19

Kamala Harris Tests Positive For COVID-19

Published

on

Kamala Harris

On Tuesday, the White House announced that Vice President Kamala Harris has tested positive for COVID-19 and is not currently showing symptoms.

“Today, Vice President Harris tested positive for COVID-19 on rapid and PCR tests,” said Kirsten Allen, press secretary to the vice president. “She has exhibited no symptoms, will isolate and continue to work from the Vice President’s residence. She has not been a close contact to the President or First Lady due to their respective recent travel schedules. She will follow CDC guidelines and the advice of her physicians. The Vice President will return to the White House when she tests negative.”

Harris wrote on Twitter that she was going to continue to isolate and is showing no symptoms.

“Today I tested positive for COVID-19. I have no symptoms, and I will continue to isolate and follow CDC guidelines. I’m grateful to be both vaccinated and boosted,” Harris tweeted.

Harris last reportedly saw President Biden at the Easter Egg Roll on April 18 before leaving for California, which she returned from on April 25.

The vice president has been vaccinated against COVID-19 and has received two booster shots, receiving the second booster on April 1.

“Yesterday I received my second COVID-19 booster shot,” Harris tweeted on April 2. “We know that getting vaccinated is the best form of protection from this virus and boosters are critical in providing an additional level of protection. If you haven’t received your first booster—do it today.”

Continue Reading

Leo's Hot List